Eggs Retrieval. Adverse Events, Complications, and Malpractice: A Medicolegal Perspective



Ovum pickup (OPU) or egg retrieval, also known as follicular or follicle puncture, is instrumental in carrying out in vitro fertilization (IVF) procedures.


Egg-retrieval Complications Medico-legal issues 


  1. 1.
    ESHRE Guideline Group on good practice in IVF labs. Revised guidelines for good practice in IVF laboratories (2015) Guideline of the European Society of Human Reproduction and Embryology. December 2015.Google Scholar
  2. 2.
  3. 3.
    Grubb A, Laing J, McHale J. Principles of medical law. New York: Oxford University Press; 2010.Google Scholar
  4. 4.
    Montanari Vergallo G, Busardò FP, Zaami S, Marinelli E. The static evolution of the new Italian code of medical ethics. Eur Rev Med Pharmacol Sci. 2016;20(3):575–80.PubMedGoogle Scholar
  5. 5.
    Law n. 24/2017 “Disposizioni in materia disicurezza delle cure e della persona assistita nonché in materia di responsabilità professionale degli esercenti le professioni sanitarie”.Google Scholar
  6. 6.
    Tucker C. Ethical and legal issues arising from the informed consent process in fertility treatments. ABA Health Law Section. Vol. 9, No. 7; March 2013.Google Scholar
  7. 7.
  8. 8.
    Dicker D, Ashkenazi J, Feldberg D, Levy T, Dekel A, Ben Rafael Z. Severe abdominal complications after transvaginal ultrasonographically guided retrieval of oocytes for in vitro fertilization and embryo transfer. Fertil Steril. 1993;59(6):1313–5.Google Scholar
  9. 9.
    Vahratian A. Prevalence of overweight and obesity among women of childbearing age: results from the 2002 National Survey of Family Growth. Matern Child Health J. 2009;13:268–73.CrossRefGoogle Scholar
  10. 10.
    Gesink Law DC, Maclehose RF, Longnecker MP. Obesity and time to pregnancy. Hum Reprod. 2007;22:414–20.CrossRefGoogle Scholar
  11. 11.
    Mitchell M, Bakos HW, Lane M. Paternal diet-induced obesity impairs embryo development and implantation in the mouse. Fertil Steril. 2011;95(4):1349–53.Google Scholar
  12. 12.
    Tamer Erel C, Senturk LM. The impact of body mass index on assisted reproduction. Curr Opin Obstet Gynecol. 2009;21(3):228–35.Google Scholar
  13. 13.
    Marquard KL, Stephens SM, Jungheim ES, Ratts VS, Odem RR, Lanzendorf S, Moley KH. Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro vaginal oocyte retrieval. Gynecol Obstet Investig. 2009;67(1):32–5.CrossRefGoogle Scholar
  14. 14.
    Robkeor RL. Evidence that obesity alters the quality of oocytes and embryos. Pathophysiology. 2008;15(2):115–21.Google Scholar
  15. 15.
    Jungheim ES, Moley KH. Current knowledge of obesity’s effects in the pre- and periconceptional periods and avenues for future research. Am J Obstet Gynecol. 2010;203(6):525–30.Google Scholar
  16. 16.
    Brewer CJ, Balen AH. The adverse effects of obesity on conception and implantation. Reproduction. 2010;140(3):347–64.Google Scholar
  17. 17.
    Purcell SH, Moley KH. The impact of obesity on egg quality. J Assist Reprod Genet. 2011;28(6):517–24.Google Scholar
  18. 18.
    Özaltın S, Kumbasar S, Sa-van K. Evaluation of complications developing during and after transvaginal ultrasound—guided oocyte retrieval. Ginekol Pol. 2018;89(1):1–6.CrossRefGoogle Scholar
  19. 19.
    Ayestaran C, Matorras R, Gomez S, Arce D, Rodriguez-Escudero F. Severe bradycardia and bradypnea following vaginal oocyte retrieval: a possible toxic effect of paracervical mepivacaine. Eur J Obstet Gynecol Reprod Biol. 2000;91(1):71–3.Google Scholar
  20. 20.
    Andersen AN, Gianaroli L, Felberbaum R, de Mouzon J, Nygren KG; European IVF-monitoring programme (EIM), European Society of Human Reproduction and Embryology (ESHRE). European IVFmonitoring programme (EIM). Assisted reproductive technology in Europe, 2001. Results generated from European registers by ESHRE. Hum Reprod. 2005;20(5):1158–76.Google Scholar
  21. 21.
    Oyawoye OA, Chander B, Hunter J, Gadir AA. Prevention of ovarian hyperstimulation syndrome by early aspiration of small follicles in hyper-responsive patients with polycystic ovaries during assisted reproductive treatment cycles. Medscape Gen Med. 2005;7(3):60.Google Scholar
  22. 22.
    Ayestaran C, Matorras R, Gomez S, Arce D, Rodriguez-Escudero F. Severe bradycardia and bradypnea following vaginal oocyte retrieval: a possible toxic effect of paracervical mepivacaine. Eur J Obstet Gynecol Reprod Biol. 2000;91(1):71–3.CrossRefGoogle Scholar
  23. 23.
    Zaami S, Montanari Vergallo G, Napoletano S, Signore F, Marinelli E. The issue of delivery room infections in the Italian law. A brief comparative study with English and French jurisprudence. J Matern Fetal Neonatal Med. 2017;31(2):1–8.Google Scholar
  24. 24.
    Ragni G, Scarduelli C, Calanna G, Santi G, Benaglia L, Somigliana E. Blood loss during transvaginal oocyte retrieval. Gynecol Obstet Investig. 2009;67(1):32–5.CrossRefGoogle Scholar
  25. 25.
    Aragona C, Mohamed MA, Espinola MS, Linari A, Pecorini F, Micara G, Sbracia M. Clinical complications after transvaginal oocyte retrieval in 7,098 IVF cycles. Fertil Steril. 2011;95(1):293–4.CrossRefGoogle Scholar
  26. 26.
    Liberty G, Hyman JH, Eldar-Geva T, Latinsky B, Gal M, Margalioth EJ. Ovarian hemorrhage after transvaginal ultrasonographically guided oocyte aspiration: a potentially catastrophic and not so rare complication among lean patients with polycystic ovary syndrome. Fertil Steril. 2008;93(3):874–9.CrossRefGoogle Scholar
  27. 27.
    Zaami S, Malvasi A, Marinelli E. Fundal pressure: risk factors in uterine rupture. The issue of liability: complication or malpractice? J Perinat Med. 2018;46(5):567–8.CrossRefGoogle Scholar
  28. 28.
    Malvasi A, Montanari Vergallo G, Tinelli A, Marinelli E. Can the intrapartum ultrasonography reduce the legal liability in dystocic labor and delivery? J Matern Fetal Neonatal Med. 2018;31(8):1108–9.CrossRefGoogle Scholar
  29. 29.
    Jayaprakasan K, Herbert M, Moody E, Stewart JA, Murdoch AP. Estimating the risks of ovarian hyperstimulation syndrome (OHSS): implications for egg donation for research. Hum Fertil. 2007;10:183–7.CrossRefGoogle Scholar
  30. 30.
    Kramer W, Schneider J, Schultz N. US oocyte donors: a retrospective study of medical and psychosocial issues. Hum Reprod. 2009;24(12):3144–9.CrossRefGoogle Scholar
  31. 31.
    American Society for Reproductive Medicine Practice Committee. Repetitive oocyte donation. Fertil Steril. 2008;90(5 Suppl):S194–5.Google Scholar
  32. 32.
    Practice Committee of the American Society for Reproductive Medicine and Practice Committee of the Society for Assisted Reproductive Technology. Repetitive oocyte donation: a committee opinion. Fertil Steril. 2014;102(4):964–6.Google Scholar
  33. 33.
    Bodri D, Guillén JJ, Polo A, Trullenque M, Esteve C, Coll O. Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles. Reprod Biomed Online. 2008;17(2):237–43.Google Scholar
  34. 34.
    Shmorgun D, Claman P, Gysler M, Hemmings R, Cheung AP, Goodrow GJ, Hughes EG, Min JK, Roberts J, Senikas V, Chee-Man Wong B, Young D. The diagnosis and management of ovarian hyperstimulation syndrome. J Obstet Gynaecol Can. 2011;33(11):1156–62.CrossRefGoogle Scholar
  35. 35.
    Mozes M, Bogokowsky H, Antebi E, Lunenfeld B, Rabau E, Serr DM, David A, Salomy M. Thromboembolic phenomena after ovarian stimulation with human gonadotrophins. Lancet. 1965;2(7424):1213–5.CrossRefGoogle Scholar
  36. 36.
    Cluroe AD, Synek BJ. A fatal case of ovarian hyperstimulation syndrome with cerebral infarction. Pathology. 1995;27(4):344–6.Google Scholar
  37. 37.
    Tang OS, Ng EH, Wai Cheng P, Chung HP. Cortical vein thrombosis misinterpreted as intracranial haemorrhage in severe ovarian hyperstimulation syndrome: case report. Hum Reprod. 2000;15(9):1913–6.Google Scholar
  38. 38.
    Semba S, Moriya T, Youssef EM, Sasano H. An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion. Pathol Int. 2000;50(7):549–52.Google Scholar
  39. 39.
    Kim H-S, Kim M, Seo I-S, Kwon TJ, Ha H, Lee B-w. An autopsy case of severe ovarian hyperstimulation syndrome with multifocal arterial and venous thromboembolism. Korean J Legal Med. 2011;35(1):57–61.Google Scholar
  40. 40.
    Zaami S. Assisted heterologous fertilization and the right of donor conceived chi1dren to know their biological origins. Clin Ter. 2018;169(1):39–43.Google Scholar
  41. 41.
    Montanari Vergallo GM, Zaami S, Bruti V, Signore F, Marinelli E. How the legislation in medical assisted procreation has evolved in Italy. Med Law. 2017;36(2):5–28.Google Scholar
  42. 42.
    Montanari VG, Marinelli E, di Luca NM, Zaami S. Gamete donation: are children entitled to know their genetic origins? A comparison of opposing views. The Italian State of Affairs. Eur J Health Law. 2018;25(3):322–37.CrossRefGoogle Scholar
  43. 43.
    Ridley J. Being an egg donor gave me terminal cancer. The New York Post. 3 Dec 2015.Google Scholar
  44. 44.
    Fauser BC, Garcia VJ. Breast cancer risk after oocyte donation: should we really be concerned? Reprod Biomed Online. 2017;34(5):439–40.CrossRefGoogle Scholar
  45. 45.
    Lawson AK, Klock SC, Pavone ME, Hirshfeld-Cytron J, Smith KN, Kazer RR. A prospective study of depression and anxiety in female fertility preservation and infertility patients. Fertil Steril. 2014;102(5):1377–84.CrossRefGoogle Scholar
  46. 46.
    Reindollar RH, Regan MM, Neumann PJ, Levine BS, Thornton KL, Alper MM, Goldman MB. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertil Steril. 2010;94(3):888–99.CrossRefGoogle Scholar
  47. 47.
    Zweifel JE, Rathert MA, Klock SC, Walaski HP, Pritts EA, Olive DL, Lindheim SR. Comparative assessment of pre- and post-donation attitudes towards potential oocyte and embryo disposition and management among ovum donors in an oocyte donation programme. Hum Reprod. 2006;21(5):1325–7.CrossRefGoogle Scholar
  48. 48.
    Gonca S, Gün I, Ovayolu A, Şilfeler D, Sofuoğlu K, Özdamar Ö, Yilmaz A, Tunali G. Effect of lower than expected number of oocyte on the IVF results after oocyte-pickup. Int J Clin Exp Med. 2014;7(7):1853–9.PubMedPubMedCentralGoogle Scholar
  49. 49.
    Christiaens F, Janssenswillen C, Verborgh C, Moerman I, Devroey P, Van Steirteghem A, Camu F. Propofol concentrations in follicular fluid during general anaesthesia for transvaginal oocyte retrieval. Hum Reprod. 1999;14(2):345–8.CrossRefGoogle Scholar
  50. 50.
    Cohen J, Gilligan A, Esposito W, Schimmel T, Dale B. Ambient air and its potential effects on conception in vitro. Hum Reprod. 1997;12(8):1742–9.CrossRefGoogle Scholar
  51. 51.
    Cohen J, Gilligan A, Willadsen S. Culture and quality control of embryos. Hum Reprod. 1998;13(Suppl 3):137–44.CrossRefGoogle Scholar
  52. 52.
    Cohen J, Jones HW. In vitro fertilization: the first three decades. In: Gardner DK, editor. In vitro fertilization: a practical approach. 1st ed. New York: Informa Healthcare USA Inc.; 2009. p. 1–13.Google Scholar
  53. 53.
    van Loendersloot LL, van Wely M, Limpens J, Bossuyt PM, Repping S, van der Veen F. Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis. Hum Reprod Update. 2010;16(6):577–89.Google Scholar
  54. 54.
    Shaban MM, Abdel Moety GA. Role of ultrasonographic markers of ovarian reserve in prediction of IVF and ICSI outcome. Gynecol Endocrinol. 2014;30(4):290–3.Google Scholar
  55. 55.
    Zaami S, Marinelli E, Montanari Vergallo G. Assessing malpractice lawsuits for death or injuries due to amniotic fluid embolism. Clin Ter. 2017;168(3):220–4.Google Scholar
  56. 56.
    Frati P, Foldes-Papp Z, Zaami S, Busardò FP. Amniotic fluid embolism: what level of scientific evidence can be drawn? a systematic review. Curr Pharm Biotechnol. 2013;14(14):1157–62.CrossRefGoogle Scholar
  57. 57.
    Laska LL. Medical malpractice verdicts, settlements & experts. April 2002. Philadelphia (Pa) Court Of Common Pleas. OBG Manag. 2002;14(4):86–8.Google Scholar
  58. 58.
    Gorrie JJ. Legal Review and Commentary: OB/GYN patient dies after egg harvest: $30 million verdict and settlements. July 1st 2001. Reference: Tony Matteo, MD, as Adm. of the Estate of Suzanne Wester Matteo, MD v. Jerome Check, MD, and Admed Nazari, MD v. Tony Matteo, MD, Holy Redeemer Hospital and Nurse Newhall, Philadelphia Court of Common Pleas. Case settled. Thomas Kline, Esq., of Philadelphia, for the plaintiff.Google Scholar
  59. 59.
    Egg donor’s death: internal bleeding, ovaries severely enlarged, says report. The Indian Report. July 4th 2014.Google Scholar
  60. 60.
    Zaami S, Busardò FP. Elective egg freezing: can you really turn back the clock? Eur Rev Med Pharmacol Sci. 2015;19(19):3537–8.PubMedGoogle Scholar
  61. 61.
    Vergallo GM. Negligence and embryo protection: a new frontier for medical law? Med Law. 2014;33(1):2–13.Google Scholar
  62. 62.
    Levine AD. Self-regulation, compensation, and the ethical recruitment of oocyte donors. Hastings Cent Rep. 2010;40(2):25–36.CrossRefGoogle Scholar
  63. 63.
    Cone KL. Family law—egg donation and stem cell research—eggs for sale: the scrambled state of legislation in the human egg market. U Ark Little Rock L Rev. 2012;35:189.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Anatomical, Histological, Forensic and Orthopedic SciencesSapienza University of RomeRomeItaly
  2. 2.The New European Surgical AcademyBerlinGermany
  3. 3.Charitè University HospitalBerlinGermany
  4. 4.ELSAN Group HospitalsParisFrance
  5. 5.Department of Obstetrics and GynecologyGVM Care and Research Santa Maria HospitalBariItaly
  6. 6.Laboratory of Human Physiology, Phystech BioMed School, Faculty of Biological and Medical PhysicsMoscow Institute of Physics and Technology (State University)DolgoprudnyRussia

Personalised recommendations